Clinical Trial Update: Febuxostat Effect on Chronic Kidney Disease Progression And Carotid Intima-Media Thickness [Phase 1]

View source ↗

Summary

Phase 1 study evaluating febuxostat's effect on chronic kidney disease progression and carotid intima-media thickness has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Carotid Artery Disease
• Chronic Kidney Disease

Drugs mentioned

• FEBUXOSTAT (Febuxostat)

Snippet

Sponsor: Ain Shams University | Conditions: Carotid Intima- Media Thickness | Phase 1 | Status: COMPLETED